secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001558370-24-010853
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q2 revenue $73.2M (+7% YoY); lowers FY 2024 guidance to $293-298M
--------------------------------------------------------------------------------

- Revenue of $73.2M, up 7% YoY; lymphedema product revenue +8%, airway clearance +2%.
- Net income of $4.3M ($0.18 diluted EPS) vs net loss of $0.1M in Q2 2023; adjusted EBITDA $9.1M.
- Full-year 2024 revenue guidance lowered to $293-298M (7-9% growth) from prior $300-305M (9-11%).
- Appointed Sheri Dodd as President and CEO effective July 1, 2024; received 510(k) clearance for Nimbl system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837024010853/0001558370-24-010853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837024010853/tcmd-20240805x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-010853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer